These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21703786)

  • 1. [Effectiveness and risks related to enteric decolonization with oral streptomycin for glycopeptide-resistant enterocci carriers].
    Gendrin V; Hénard S; Petitfrère M; May T; Rabaud C
    Med Mal Infect; 2011 Oct; 41(10):563-4. PubMed ID: 21703786
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
    Abb J
    Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infection caused by glycopeptide resistant pathogens].
    Korn SJ; Stille W
    Internist (Berl); 2000 Dec; 41(12):1344-52. PubMed ID: 11189069
    [No Abstract]   [Full Text] [Related]  

  • 4. Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates.
    Hoehn R; Groll AH; Schaefer V; Bauer K; Schloesser RL
    Int J Antimicrob Agents; 2006 Mar; 27(3):256-8. PubMed ID: 16480855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycopeptide-resistant Enterococcus faecium in a hospital in northern Spain. Molecular characterization and clinical epidemiology].
    Torres E; Pérez S; Vindel A; Rodríguez-Baño J; Camba V; Villanueva R; Coque TM; Bou G
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):511-7. PubMed ID: 19477049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of carriage of glycopeptide-resistant enterococci by at-risk hospitalised patients in Malta.
    Decelis S; Borg MA; Cuschieri P
    Clin Microbiol Infect; 2004 Sep; 10(9):861-2. PubMed ID: 15355423
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
    Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
    Młynarczyk G; Grzybowska W; Młynarczyk A; Tyski S; Kawecki D; Łuczak M; Chmura A; Rowiński W
    Transplant Proc; 2007 Nov; 39(9):2883-5. PubMed ID: 18022008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 11. [Implementation of vanA and vanB genes by PCR technique research interest in system (Xpert vanA/vanB CepheidR) closed in a laboratory of microbiology in managing an outbreak to Enterococcus faecium resistant glycopeptide (EfRG)].
    Dekeyser S; Beclin E; Descamps D
    Pathol Biol (Paris); 2011 Apr; 59(2):73-8. PubMed ID: 20828941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract]   [Full Text] [Related]  

  • 14. First emergence of glycopeptide-resistant enterococci infections in Greece.
    Routsi C; Platsouka E; Armaganidis A; Paniara O; Roussos C
    Scand J Infect Dis; 2001; 33(1):80. PubMed ID: 11234989
    [No Abstract]   [Full Text] [Related]  

  • 15. Enterococcus faecium isolated from bone marrow transplant patients in Tunisia: high prevalence of antimicrobial resistance and low pathogenic power.
    Abbassi MS; Achour W; Touati A; Ben Hassen A
    Pathol Biol (Paris); 2009 May; 57(3):268-71. PubMed ID: 18394823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of Enterococcus genus to new antimicrobial agents].
    Sánchez-Molina MI; Martín D; Valladares C; Gastañares MJ; Torres C; Borque L
    Rev Esp Quimioter; 2004 Jun; 17(2):184-8. PubMed ID: 15470513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Streptogramins and glycopeptides].
    Tsuji A
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():360-6. PubMed ID: 17455646
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between antibiotic resistance and virulence factors in urinary Enterococcus isolates].
    Baylan O; Nazik H; Bektöre B; Citil BE; Turan D; Ongen B; Ozyurt M; Açıkel CH; Haznedaroğlu T
    Mikrobiyol Bul; 2011 Jul; 45(3):430-45. PubMed ID: 21935776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
    Werner G; Klare I; Spencker FB; Witte W
    J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.